Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001209191-23-047102

President and CEO sold 5,210 shares at $16.66 ($86,779)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Fordyce Marshall President and CEO 2023-08-21 Sale 10b5-1 −5,210 $16.66 $86,779 243,361 D: show line 1 in the form
Open-market sales · 5,210 sh · avg $16.66 · $86,779
Loading xslF345X05/doc4.xml…